PLACEBO- AND AMITRIPTYLINE-CONTROLLED EVALUATION OF CENTRAL NERVOUS SYSTEM EFFECTS OF THE NK1 RECEPTOR ANTAGONIST APREPITANT AND INTRAVENOUS ALCOHOL INFUSION